PE Tech Report


Like this article?

Sign up to our free newsletter

Sobera Capital acquires international portfolio of direct interests from Innoveas

Sobera Capital has acquired a portfolio of 12 minority and majority equity holdings in private companies mainly in the life sciences sector from Innoveas International Ltd.

The assets, which include, among others, interests in Presidio Pharmaceuticals, EffRx Pharmaceuticals, MORE Medical Solutions, Axellis Ventures and MyoScience, are based mainly in Europe and the US. Sobera Capital was backed in this secondary direct transaction by several family offices and entrepreneurs.
Sobera Capital is a Berlin based independent secondary direct investor with a focus on growth and small-cap funds and assets in TIMES, healthcare and selected other industries.

Like this article? Sign up to our free newsletter